Checkmate017_2B: Checkmate017, figure 2B

Checkmate017_2BR Documentation

Checkmate017, figure 2B

Description

Kaplan-Meier digitized data from Checkmate017, figure 2B (PMID 26028407). A reported sample size of 272 for a primary endpoint of OS in lung cancer.

Usage

Checkmate017_2B

Format

A data frame of 272 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (d1, nivolumab)

Source

Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med 2015; 373: 123–35.

Examples

summary(Checkmate017_2B)

kmplot(Checkmate017_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.